Virdante Pharmaceuticals' Series A Round

Virdante Pharmaceuticals raised a round of funding on October 15, 2009.

Virdante Pharmaceuticals is developing safer and more effective drugs for autoimmune and inflammatory diseases. The company's products incorporate a proprietary sialic switch technology to improve the…

Articles about Virdante Pharmaceuticals' Series A Round: